NDC 36987-3418

Saltbush

Saltbush

Saltbush is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Atriplex Wrightii Pollen.

Product ID36987-3418_c6c9737f-cac3-445a-b895-e2dacca18a0f
NDC36987-3418
Product TypeHuman Prescription Drug
Proprietary NameSaltbush
Generic NameSaltbush
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1972-08-29
Marketing CategoryBLA / BLA
Application NumberBLA102192
Labeler NameNelco Laboratories, Inc.
Substance NameATRIPLEX WRIGHTII POLLEN
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 36987-3418-2

10 mL in 1 VIAL, MULTI-DOSE (36987-3418-2)
Marketing Start Date1972-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 36987-3418-4 [36987341804]

Saltbush INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-3418-3 [36987341803]

Saltbush INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-3418-2 [36987341802]

Saltbush INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-3418-1 [36987341801]

Saltbush INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
ATRIPLEX WRIGHTII POLLEN.05 g/mL

OpenFDA Data

SPL SET ID:ccd1d7d8-c5de-4cdb-b1e7-a3b114394fd4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 851933
  • 852049
  • 851937
  • 852327
  • 852596
  • 897335
  • 852535
  • 995746
  • 852082
  • 897394
  • 852240
  • 897506
  • 897319
  • 851929
  • 852010
  • 851988
  • 896249
  • 852155
  • 851893
  • 852216
  • 851897
  • 852212
  • 852745
  • 851941
  • 852529
  • 852077
  • 852099
  • 897307
  • 852542
  • 852554
  • 895922
  • 852001
  • 852161
  • 852032
  • 851972
  • 852023
  • 995604
  • Pharmacological Class

    • Non-Standardized Pollen Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Increased IgG Production [PE]
    • Pollen [CS]
    • Allergens [CS]

    NDC Crossover Matching brand name "Saltbush" or generic name "Saltbush"

    NDCBrand NameGeneric Name
    36987-3413SaltbushSaltbush
    36987-3414SaltbushSaltbush
    36987-3415SaltbushSaltbush
    36987-3416SaltbushSaltbush
    36987-3417SaltbushSaltbush
    36987-3418SaltbushSaltbush
    36987-3419SaltbushSaltbush
    36987-3420SaltbushSaltbush

    Trademark Results [Saltbush]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SALTBUSH
    SALTBUSH
    98297249 not registered Live/Pending
    Red Matter IP LLC
    2023-12-04

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.